215
Views
0
CrossRef citations to date
0
Altmetric
Preliminary Communication

Lycorine-Derived Phenanthridine Downregulators of Host Hsc70 as Potential Hepatitis C Virus Inhibitors

, , , , , , , , , , , & show all
Pages 561-570 | Published online: 29 Apr 2015
 

Abstract

Background: A new series of potential phenanthridine hepatitis C virus (HCV) inhibitors which work by suppressing Hsc70 expression in the host cell was designed and synthesized from lycorine. Results: Thirty-one new potential phenanthridine HCV inhibitors were synthesized and five of these compounds exhibited good anti-HCV activity and these inhibitors probably inhibit HCV by downregulating the host Hsc70 expression. Structure-activity analysis of these compounds revealed that the double bond between C-11 and C-12 and the substituents at C-8 and C-9 are important for their activity against HCV. Conclusion: Suppression of Hsc70 expression in the host cell to limit HCV replication is a potential anti-HCV strategy. Phenanthridines are probably the HCV inhibitors with this mode of action.

Acknowledgements

We thank W Wang (Kunming Institute of Botany, Chinese Academy of Sciences, China) for providing help with purifying the compounds used in this study.

Financial & competing interests disclosure

This research was financially supported by the National Natural Science Foundation of China (81402828 and 21432010) and the “Xi Bu Zhi Guang” Foundation of The Chinese Academy of Sciences. The authors have no other relevant affiliations or financial involvement with any organization or entity with a financial interest in or financial conflict with the subject matter or materials discussed in the manuscript apart from those disclosed.

No writing assistance was utilized in the production of this manuscript.

Additional information

Funding

This research was financially supported by the National Natural Science Foundation of China (81402828 and 21432010) and the “Xi Bu Zhi Guang” Foundation of The Chinese Academy of Sciences. The authors have no other relevant affiliations or financial involvement with any organization or entity with a financial interest in or financial conflict with the subject matter or materials discussed in the manuscript apart from those disclosed.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.